Author,Source,Type,Assay,Stage,Sensitivity,True Pos,Actual Pos
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,FTA-ABS,primary,0.9920,127,128
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,FTA-ABS,secondary,1.0000,243,243
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,FTA-ABS,early latent,0.9870,137,139
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,MHA-TP,primary,0.8860,113,128
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,MHA-TP,secondary,0.9880,240,243
Augenbraun (1998),"Augenbraun, 1998
Sexually Transmitted Diseases 25(10): 549-552.",manual treponemal,MHA-TP,early latent,1.0000,139,139
Byrne (1992),"Byrne, R. E., et al. (1992). Journal of Clinical Microbiology 30(1): 115-122.",manual treponemal,FTA-ABS,primary,0.8890,8,9
Byrne (1992),"Byrne, R. E., et al. (1992). Journal of Clinical Microbiology 30(1): 115-122.",manual treponemal,FTA-ABS,secondary,1.0000,13,13
Byrne (1992),"Byrne, R. E., et al. (1992). Journal of Clinical Microbiology 30(1): 115-122.",manual treponemal,FTA-ABS,late latent,0.8300,5,6
Byrne (1992),"Byrne, R. E., et al. (1992). Journal of Clinical Microbiology 30(1): 115-122.",manual treponemal,FTA-ABS,primary,0.9000,36,40
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,FTA-ABS,primary,0.8200,52,63
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,FTA-ABS,secondary,1.0000,43,43
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,FTA-ABS,early latent,0.9800,52,53
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,FTA-ABS,late latent,0.9800,85,87
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,MHA-TP,primary,0.6400,40,63
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,MHA-TP,secondary,0.9600,41,43
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,MHA-TP,early latent,0.9600,51,53
Coffey (1972),"Coffey, E. M., et al. (1972). ""Evaluation of the qualitative and automated quantitative microhemagglutination assay for antibodies to Treponema pallidum."" Applied Microbiology 24(1): 26-30.",manual treponemal,MHA-TP,late latent,0.9700,84,87
Farshy (1983),"Farshy, C. E., et al. (1983). Journal of Clinical Microbiology 17(2): 245-248.",manual treponemal,FTA-ABS,primary,0.8000,4,5
Farshy (1983),"Farshy, C. E., et al. (1983). Journal of Clinical Microbiology 17(2): 245-248.",manual treponemal,FTA-ABS,secondary,1.0000,7,7
Farshy (1983),"Farshy, C. E., et al. (1983). Journal of Clinical Microbiology 17(2): 245-248.",manual treponemal,FTA-ABS,early latent,1.0000,15,15
Huber (1983),"Huber, T. W., et al. (1983). Journal of Clinical Microbiology 17(3): 405-409.",manual treponemal,FTA-ABS,primary,0.9820,107,109
Huber (1983),"Huber, T. W., et al. (1983). Journal of Clinical Microbiology 17(3): 405-409.",manual treponemal,MHA-TP,primary,0.7250,79,109
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1987)."" European Journal of Clinical Microbiology 6(3): 281-285.",manual treponemal,FTA-ABS,primary,0.9000,45,50
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1987)."" European Journal of Clinical Microbiology 6(3): 281-285.",manual treponemal,FTA-ABS,secondary,1.0000,43,43
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1987)."" European Journal of Clinical Microbiology 6(3): 281-285.",manual treponemal,FTA-ABS,early latent,1.0000,47,47
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1989).  Journal of Clinical Microbiology 27(1): 152-157.",manual treponemal,FTA-ABS,primary,0.8400,46,55
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1989).  Journal of Clinical Microbiology 27(1): 152-157.",manual treponemal,FTA-ABS,secondary,1.0000,39,39
Ijsselmuiden (1987),"Ijsselmuiden, O. E., et al. (1989).  Journal of Clinical Microbiology 27(1): 152-157.",manual treponemal,FTA-ABS,early latent,1.0000,54,54
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,FTA-ABS,primary,1.0000,17,17
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,FTA-ABS,secondary,1.0000,23,23
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,FTA-ABS,latent,1.0000,27,27
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,MHA-TP,primary,0.7640,13,17
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,MHA-TP,secondary,1.0000,23,23
Jaffe (1978),"Jaffe, H. W., et al. (1978). American Journal of Clinical Pathology 70(2): 230-233",manual treponemal,MHA-TP,latent,1.0000,27,27
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,FTA-ABS,primary,0.9750,77,79
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,FTA-ABS,secondary,0.9900,88,89
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,FTA-ABS,latent,1.0000,103,103
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,MHA-TP,primary,0.8860,70,79
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,MHA-TP,secondary,1.0000,89,89
Larsen (1981),"Larsen, S. A., et al. (1981) Journal of Clinical Microbiology 14(4): 441-445.",manual treponemal,MHA-TP,latent,0.9900,102,103
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,FTA-ABS,primary,0.8460,33,39
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,FTA-ABS,secondary,0.9500,19,20
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,FTA-ABS,early latent,0.9440,17,18
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,FTA-ABS,latent,0.8450,49,58
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,TP-PA,primary,0.9490,37,39
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,TP-PA,secondary,1.0000,20,20
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,TP-PA,early latent,0.9440,17,18
Lam (2010),"Lam, TK (2010)
 International Journal of STD & AIDS 21(2): 110-113.",manual treponemal,TP-PA,latent,0.9140,53,58
Moyer (1984),"Moyer, N. P., et al. (1984). Journal of Clinical Microbiology 19(6): 849-852.",manual treponemal,FTA-ABS,all,0.9837,121,123
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,TP-PA,primary,0.9450,52,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,TP-PA,secondary,1.0000,98,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,TP-PA,early latent,1.0000,41,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,TP-PA,late latent,0.8680,59,68
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,FTA-ABS,primary,0.7820,43,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,FTA-ABS,secondary,0.9280,91,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,FTA-ABS,early latent,1.0000,41,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),manual treponemal,FTA-ABS,late latent,0.9260,63,68
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,FTA-ABS,primary,1.0000,24,24
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,FTA-ABS,secondary,1.0000,20,20
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,FTA-ABS,latent,1.0000,35,35
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,MHA-TP,primary,0.4583,11,24
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,MHA-TP,secondary,0.9000,18,20
Pope (1982)," Pope, V., et al. (1982). Journal of Clinical Microbiology 15(4): 630-634",manual treponemal,MHA-TP,latent,0.8000,28,35
Romanowski (1987),"Romanowski, B., et al. (1987).  .""Sexually Transmitted Diseases 14(3): 156-159",manual treponemal,FTA-ABS,all,0.9242,61,66
Van (1986),"Van Eijk, R. V. W., et al. (1986). Sexually Transmitted Infections 62(6): 367-372.",manual treponemal,FTA-ABS,primary,0.8364,46,55
Van (1986),"Van Eijk, R. V. W., et al. (1986). Sexually Transmitted Infections 62(6): 367-372.",manual treponemal,FTA-ABS,secondary,1.0000,39,39
Van (1986),"Van Eijk, R. V. W., et al. (1986). Sexually Transmitted Infections 62(6): 367-372.",manual treponemal,FTA-ABS,latent,0.2593,14,54
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",manual treponemal,FTA-ABS,primary,0.9167,22,24
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",manual treponemal,FTA-ABS,secondary,0.8696,20,23
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",manual treponemal,FTA-ABS,early latent,0.8182,9,11
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",manual treponemal,FTA-ABS,late latent,1.0000,31,31
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",manual treponemal,FTA-ABS,uncertain,0.9286,13,14
Dyckman (1980),"Dyckman, J. D., et al. (1980). Journal of Clinical Microbiology 12(4): 629-630.",manual treponemal,FTA-ABS,primary,0.9150,119,130
Dyckman (1980),"Dyckman, J. D., et al. (1980). Journal of Clinical Microbiology 12(4): 629-630.",manual treponemal,MHA-TP,primary,0.8230,107,130
Bosshard (2013),"Bosshard 2013
Journal of Infection 67(1): 35-42.",manual treponemal,TP-PA,primary,1.0000,59,59
Bosshard (2013),"Bosshard 2013
Journal of Infection 67(1): 35-42.",manual treponemal,TP-PA,secondary,1.0000,66,66
Bosshard (2013),"Bosshard 2013
Journal of Infection 67(1): 35-42.",manual treponemal,TP-PA,latent,1.0000,25,25
Creegan (2007),"Creegan (2007)
Sex Transm Dis. 2007 Dec;34(12):1016-1018.",manual treponemal,TP-PA,primary,0.8590,78,91
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",manual treponemal,TP-PA,all,0.9579,109,114
Liu (2014),"Liu, C., et al. (2014). Journal of Clinical Laboratory Analysis 28(3): 204-209.",manual treponemal,TP-PA,all,0.9625,154,160
Manavi (2006),"Manavi, K., et al. (2006). International Journal of STD & AIDS 17(11): 768-771.",manual treponemal,TP-PA,primary,0.9600,48,50
Manavi (2006),"Manavi, K., et al. (2006). International Journal of STD & AIDS 17(11): 768-771.",manual treponemal,TP-PA,secondary,1.0000,26,26
Manavi (2006),"Manavi, K., et al. (2006). International Journal of STD & AIDS 17(11): 768-771.",manual treponemal,TP-PA,early latent,1.0000,8,8
Manavi (2006),"Manavi, K., et al. (2006). International Journal of STD & AIDS 17(11): 768-771.",manual treponemal,TP-PA,uncertain,1.0000,21,21
Pope (2000),"Pope, V., et al. (2000).   Journal of Clinical Microbiology 38(7): 2543-2545",manual treponemal,TP-PA,primary,0.8750,21,24
Pope (2000),"Pope, V., et al. (2000).   Journal of Clinical Microbiology 38(7): 2543-2545",manual treponemal,TP-PA,secondary,1.0000,50,50
Pope (2000),"Pope, V., et al. (2000).   Journal of Clinical Microbiology 38(7): 2543-2545",manual treponemal,TP-PA,latent,0.9615,25,26
Wellinghausen (2011),"Wellinghausen, N. and H. Dietenberger (2011).  Clinical Chemistry & Laboratory Med 49(8): 1375-1377.",manual treponemal,TP-PA,all,1.0000,50,50
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,ADVIA Centaur,primary,0.9455,52,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,ADVIA Centaur,secondary,1.0000,98,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,ADVIA Centaur,early latent,1.0000,41,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,ADVIA Centaur,late latent,0.9412,64,68
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,ADVIA Centaur,all,0.9733,255,262
Liu (2014),"Liu, C., et al. (2014). Journal of Clinical Laboratory Analysis 28(3): 204-209.",treponemal immunoassays,Architect Syphilis,all,1.0000,160,160
Marangoni (2009),"Marangoni, A., et al. (2009). ""Laboratory Journal of Clinical Laboratory Analysis 23(1): 1-6.",treponemal immunoassays,Architect Syphilis,all,0.9918,242,244
Saral (2012),"Saral, Y., et al. (2012). Acta Dermatovenerologica Croatica 20(2): 84-88.",treponemal immunoassays,Architect Syphilis,all,0.9800,110,112
Wellinghausen (2011),"Wellinghausen, N. and H. Dietenberger (2011).  Clinical Chemistry & Laboratory Med 49(8): 1375-1377.",treponemal immunoassays,Architect Syphilis,all,1.0000,17,17
Xia (2018),"XIA C. J Infect Chemother (2018), https://doi.org/10.1016/j.jiac.2018.07.017",treponemal immunoassays,Architect Syphilis,all,1.0000,57,57
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,primary,0.9091,10,11
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,secondary,1.0000,35,35
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,early latent,1.0000,28,28
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,late latent,0.9762,123,126
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,tertiary,0.9464,53,56
Xu (2016),"Xu, M., et al. (2016).  International Journal of Infectious Diseases 43: 51-57.",treponemal immunoassays,Architect Syphilis,all,0.9727,249,256
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Bioplex 2200 Syphilis IgG,primary,0.9636,53,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Bioplex 2200 Syphilis IgG,secondary,1.0000,98,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Bioplex 2200 Syphilis IgG,early latent,0.9512,39,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Bioplex 2200 Syphilis IgG,late latent,0.9412,64,68
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Bioplex 2200 Syphilis IgG,all,0.9924,262,264
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",treponemal immunoassays,Captia Syphilis-G Assay,primary,0.8485,28,33
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",treponemal immunoassays,Captia Syphilis-G Assay,secondary,0.9737,37,38
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",treponemal immunoassays,Captia Syphilis-G Assay,early latent,1.0000,15,15
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",treponemal immunoassays,Captia Syphilis-G Assay,late latent,1.0000,4,4
Cole (2007),"Cole, M. J., et al. (2007). European Journal of Clinical Microbiology & Infectious Diseases 26(10): 705-713.",treponemal immunoassays,Captia Syphilis-G Assay,all,0.9333,84,90
Lefevre (1990),"Lefevre, J. C., et al. (1990). Journal of Clinical Microbiology 28(8): 1704-1707.",treponemal immunoassays,Captia Syphilis-G Assay,primary,0.8235,14,17
Lefevre (1990),"Lefevre, J. C., et al. (1990). Journal of Clinical Microbiology 28(8): 1704-1707.",treponemal immunoassays,Captia Syphilis-G Assay,secondary,1.0000,13,13
Lefevre (1990),"Lefevre, J. C., et al. (1990). Journal of Clinical Microbiology 28(8): 1704-1707.",treponemal immunoassays,Captia Syphilis-G Assay,early latent,1.0000,14,14
Lefevre (1990),"Lefevre, J. C., et al. (1990). Journal of Clinical Microbiology 28(8): 1704-1707.",treponemal immunoassays,Captia Syphilis-G Assay,late latent,1.0000,33,33
Lefevre (1990),"Lefevre, J. C., et al. (1990). Journal of Clinical Microbiology 28(8): 1704-1707.",treponemal immunoassays,Captia Syphilis-G Assay,all,1.0000,72,72
Silletti (1995),R. P. Silletti. Journal of Clinical Microbiology (1995),treponemal immunoassays,Captia Syphilis-G Assay,all,1.0000,46,46
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",treponemal immunoassays,Captia Syphilis-G Assay,primary,0.9583,23,24
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",treponemal immunoassays,Captia Syphilis-G Assay,secondary,0.9130,21,23
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",treponemal immunoassays,Captia Syphilis-G Assay,early latent,1.0000,11,11
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",treponemal immunoassays,Captia Syphilis-G Assay,late latent,1.0000,31,31
Young (1998),"Young, H., et al. (1998). Journal of Clinical Microbiology 36(4): 913-917.",treponemal immunoassays,Captia Syphilis-G Assay,all,0.9524,100,105
Xia (2018),"XIA C. J Infect Chemother (2018), https://doi.org/10.1016/j.jiac.2018.07.017",treponemal immunoassays,Elecsys Syphilis,all,1.0000,57,57
Marangoni (2005),"Marangoni (2005)
"" Clinical & Diagnostic Laboratory Immunology 12(10): 1231-1234.",treponemal immunoassays,LIAISON,primary,1.0000,7,7
Marangoni (2005),"Marangoni (2005)
"" Clinical & Diagnostic Laboratory Immunology 12(10): 1231-1234.",treponemal immunoassays,LIAISON,secondary,1.0000,31,31
Marangoni (2005),"Marangoni (2005)
"" Clinical & Diagnostic Laboratory Immunology 12(10): 1231-1234.",treponemal immunoassays,LIAISON,latent,0.9870,76,77
Marangoni (2005),"Marangoni (2005)
"" Clinical & Diagnostic Laboratory Immunology 12(10): 1231-1234.",treponemal immunoassays,LIAISON,all,0.9924,130,131
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,LIAISON,primary,0.9640,53,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,LIAISON,secondary,1.0000,98,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,LIAISON,early latent,0.9760,40,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,LIAISON,late latent,0.9260,63,68
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,LIAISON,all,0.9690,254,262
Wellinghausen (2011),"Wellinghausen, N. and H. Dietenberger (2011).  Clinical Chemistry & Laboratory Med 49(8): 1375-1377.",treponemal immunoassays,LIAISON,all,1.0000,18,18
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Trep-Sure,primary,0.9455,52,55
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Trep-Sure,secondary,1.0000,98,98
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Trep-Sure,early latent,1.0000,41,41
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Trep-Sure,late latent,0.9853,67,68
Park (2019),I. U. Park et al. Clinical Infectious Diseases(2019),treponemal immunoassays,Trep-Sure,all,0.9847,258,262